Skip to main content
Log in

Intermittent triple antiretroviral therapy: higher mortality rate

  • Clinical study
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Intermittent triple antiretroviral therapy: higher mortality rate. Inpharma Wkly. 1342, 17 (2002). https://doi.org/10.2165/00128413-200213420-00035

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200213420-00035

Keywords

Navigation